Although the 2‐year survival of the HVAD patients as compared to the HM3 patients in the matched cohorts of the EUROMACS registry did not reach statistical significance [HVAD 61% (95% confidence interval 56–67%) vs.
← all excerpts
The ever-changing field of mechanical circulatory support: new challenges at the advent of the 'single device era'.
1
—
—